Starch Capsules Market Analysis

The global starch capsules market is segmented by source material into pectin, carrageenan, agar, gelatin and others. The gelatin blended capsules are the most common form of starch capsules that are used by manufacturers in the pharmaceutical and nutraceutical industries. Backed by numerous favorable properties of gelatin blended capsules, such as, superior mechanical resistance, lower melting point, better product compatibility and stability while used along with starch as raw material, the segment is anticipated to touch USD 795.91 million by the end of 2036. 

The global starch capsules market is further segmented by form into liquid and powder, out of which, the powder segment constituted to the largest market share in the year 2019 and is anticipated to hold the highest share in the market throughout the forecast period. Based on size, the global starch capsules market is segmented into 0,00 & 000, 0 to 2, 3 to 5 and above 5. Out of these, the 0 to 2 segment held the largest market share of 60.55% in the year 2019 and is considered ideal for those who have trouble swallowing a relatively large  capsule.

The global starch capsules market is also segmented by application into health supplements, antibiotics & anti-inflammatory, antacid & laxatives, analgesics, antifungal, sedative, cardiovascular and others. The cardiovascular segment registered the highest value of USD 306.16 million in the year 2019 on account of the increasing prevalence of cardiovascular diseases amongst the population worldwide. Based on product, the market is segmented into hard and soft capsules, where the hard capsules segment registered the largest market share, backed by its utilization across a vast majority of the formulated medications. Hard capsules, unlike the soft capsules, are usually made of two parts that include the cap and a body of different colors. The hard capsules are often used to hold dry ingredients in powder form.

The global starch capsules market is also segmented based on end user into pharmaceutical, cosmeceutical and nutraceutical companies. Out of these, the pharmaceutical industry segment held a significant share of the market and is anticipated to grow with a CAGR of 6.46% during the forecast period. Rising R&D investments, increasing healthcare expenditures and the growing need for advanced pharmaceuticals are some of the factors anticipated to drive the growth of the segment in the global starch capsules market.